The Valley Desk

NCT06730126 · Interventional trial

Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

Overall registry status Recruiting

Phase 2

Conditions Autoimmune Lymphoproliferative Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov